A Real-world Study on the Assessment of Pathological Characteristics and Targeted Therapeutic Effect of Non-small Cell Lung Cancer Patients with Positive Driving Genes and High PD-L1 Expression

A Real-world Study on the Assessment of Pathological Characteristics and Targeted Therapeutic Effect of Non-small Cell Lung Cancer Patients with Positive Driving Genes and High PD-L1 Expression

Background and objective Targeted therapy for patients with driver genes positive and immunotherapy for patients with driver gene-negative but high programmed death ligand 1 (PD-L1) expression are the standards of first-line treatment for patients with advanced non-small cell lung cancer (NSCLC). Th...

Full description

Bibliographic Details
Main Authors: Hui ZHANG, Xinjie YANG, Kun LI, Jinghui WANG, Jialin LV, Xi LI, Xinyong ZHANG, Na QIN, Quan ZHANG, Yuhua WU, Li MA, Fei GAI, Ying HU, Shucai ZHANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2021-02-01
Series:Chinese Journal of Lung Cancer
Subjects:
lung neoplasms
driver mutation
programmed death-ligand 1
targeted treatment
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2021.104.02

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2021.104.02

Similar Items